BCR/ABL regulation of PI-3 kinase activity

Leukemia and Lymphoma

Volumn 23, Issue 5-6, 1996, Pages 473-476

  Calabretta, Bruno ^a   Skorski, Tomasz ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

BCR ABL regulation; PI 3 kinase activity

Indexed keywords

BCR ABL PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; WORTMANNIN;

CELL TRANSFORMATION; ENZYME REGULATION; HEMATOPOIETIC CELL; PRIORITY JOURNAL; REVIEW;

EID: 0030447567     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054856     Document Type: Review

References (41)

1. Carpenter, C. L., Duckworth, B. C., Auger, K. R , Cohen, B., Schaffhausen, B. S. and Cantley, L. C. (1990) Purification and characterization of phosphoinositide 3-kinase from rat liver. J. Biol. Chem., 265, 19704-19711.
2. Whitman, M., Downes, C. P., Keeler, M., Keller, T. and Cantley, L. C. (1988) Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidyl inositol-3-phosphate. Nature, 332, 644-646.
3. Auger, K. R., Serunian, L A., Soltoff, S. P., Libby, P. and Cantley, L. C. (1989) PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells Cell, 57, 167-175.
4. 3 interacts with SH2 domains and modulates PI 3-kinase association with tyrosine-phosphorylated proteins. Cell, 83, 821-830.
5. Cantley, L. C., Auger, K. R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R. and Soltoff, S. (1991) Oncogenes and signal transduction. Cell, 64, 281-290.
6. Escobedo, J. A., Navankasattuses, S., Kavanaugh, W. M., Milfay, D., Freid, V. A. and Williams, L. T. (1991) cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI 3-kinase to the PDGF β-receptor. Cell, 65, 75-82.
7. Skolnik, E. Y., Margolis, B., Mohammadi, M., Lowenstein, E., Fischer, R., Drepps, A., Ulbuch, A. and Schlessinger, J. (1991) Cloning of PI 3-kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell, 65, 83-90.
8. c-src complexes, and PI 3-kinase. Cell, 65, 91-104.
9. Kapeller, R., Prasad, K. V., Janssen, O., Hou, W., Schaffhausen, B. S , Rudd, C. E. and Cantley, L. C. (1994) Identification of two SH3-binding motifs in the regulatory subunit of phosphatidylinositol 3-kinase. J. Biol Chem , 269, 1927-1933.
10. Coughlin, S. R., Escobedo, J. A. and Williams, L. T. (1989) Role of phosphatidylinositol kinase in PDGF receptor signal transduction. Science, 243, 1191-1194.
11. v-src and alter cellular morphology. J. Virol., 66, 1866-1872.
12. Roche, S., Koegl, M , Courtneidge, S. A. (1994) The phosphatidylinositol 3-kinase a is required for DNA synthesis induced by some, but not all, growth factors Proc. Natl. Acad. Sci. USA, 91, 9185-9189.
13. 1 chromosome. Proc. Natl. Acad. Sci. USA, 84, 6558-6562.
14. bcr/abl gene of the Philadelphia chromosome. Science, 247, 824-830.
15. Heisterkamp, N., Jenster, G., ten Hoeve, J., Zovich, D., Pottengale, P. K. and Groffen, J. (1990) Acute leukemia in bcr-abl transgenic mice. Nature, 344, 251-253
16. Szczylik, C., Skorski, T., Nicolaides, N. C., Manzella, L., Malaguarnera, L., Venturelli, D., Gewirtz, A. M. and Calabretta, B. (1991) Selective inhibition of leukemia cell proliferation by bcr/abl antisense oligodeoxy nucleotides. Science, 253, 562-565.
17. 1 leukemia cell growth in mice by bcr/abl antisense oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA, 91, 4504-4508.
18. Lugo, T. G., Pendergast, A. M., Muller, A. J. and Witte, O. N. (1990) Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science, 247, 1079-1083.
19. Sawyers, C. L., Callahan, W. and Witte, O. N. (1992) Dominant negative MYC blocks transformation by ABL oncogenes. Cell, 70, 901-910.
20. Sawyers, C. L., McLaughlin, J. and Witte, O. N. (1995) Genetic requirement for RAS in the transformation of fibroblasts and hematopoietic cells by the BCR-ABL oncogene. J. Exp. Med., 181, 307-313.
21. Raitano, A. B., Hapern, R. J., Hambuch, M. T. and Sawyers, C. L. (1995) The BCR-ABL leukemia oncogene activates Jun Kinase and requires Jun for transformation. Proc. Natl. Acad Sci. USA, 92, 11746-11750.
22. bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth. J. Exp. Med., 179, 1855-1865.
23. Skorski, T., Nieborowska-Skorska, M., Szczylik, C., Kanakaraj, P., Perrotti, D., Zon, G., Gewirtz, A., Perussia, B. and Calabretta, B. (1995) c-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesis. Cancer Res., 55, 2275-2278.
24. Skorski, T., Nieborowska-Skorska, M., Campbell, K., Iozzo, R. V., Zon, G., Darzynkiewicz, A. and Calabretta, B. (1995) Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes. J. Exp. Med., 182, 1645-1653.
25. Skorski, T., Kanakaraj, P., Nieborowski-Skorska, M., Ratajczak, M. Z., Wen, S.-C., Zon, G., Gewirtz, A. M , Perussia, B and Calabretta, B. (1995) Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells. Blood, 86, 726-736.
26. Varticoviski, L., Daley, G. Q , Jackson, P., Baltimore, D and Cantley, L. C. (1991) Activation of phosphatydilinositol 3-kinase in cells expressing abl oncogene variants. Mol. Cell Biol., 11, 1107-1113.
27. Pleiman, C. M., Hertz, W. M and Cambier, J. C. (1994) Activation of phosphatidylinositol 3′-kinase by Src-family kinase SH3 binding to the p85 subunit. Science, 263, 1609-1612.
28. Rordorf-Nikolic, T., Van Horn, D. J , Chen, D , White, M. F and Backer, J. M. (1995) Regulation of phosphatidylinositol 3′-kinase by tyrosyl phosphoproteins. J. Biol. Chem., 270, 3662-3666.
29. Blake, T. J., Shapiro, M., Morse, H. C. III and Langdon, W. Y. (1991) The sequences of the human and mouse c-cbl proto-oncogenes show v-abl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene, 6, 653-657.
30. Andoniou, C. E., Thiess, C. B. F. and Langdon, W. Y. (1994) Tumor induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. EMBO J., 113, 4515-4523.
31. Varticovski, L., personal communication.
32. Harrison-Findick, D., Susa, M. and Vorticovski, L. (1995) Association of phosphatidylinositol 3-kinase with SHC in chronic myelogeneous leukemic cells. Oncogene, 10, 1385-1391.
33. Puil, L., Liu, J., Gish, G., Mbamalu, G., Bowtell, D., Pellicci, P. G., Arlinghaus, R. and Pawson, T. (1994) BCR-ABL oncoproteins bind directly to activators of the RAS signalling pathway. EMBO J., 13, 764-773
34. Goga, A., McLaughlin, J., Afar, D. E. H , Sawyers, C. L and Witte, O. N. (1995) Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene. Cell, 82, 981-988.
35. Franke, T. F., Yang, S-H, Chen, T. O., Datta, K., Kazlauskas, A., Morrison, D. K., Kaplan, D. R. and Tsichlis, P. N (1995) The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell, 81, 727-736.
36. Valius, M. and Kazlauskas, A (1993) Phospholipase C-γ1 and phosphatidylinositol 3-kinase are the downstream mediator of the PDGF receptor's mitogenic signal. Cell, 73, 321-334.
37. Satoh, T., Fantl, W. J., Escobedo, J. A. Williams, L T. and Kazuro, Y. (1993) Platelet derived growth factor receptor mediates activation of Ras through different signalling pathways in different cell types Mol. Cell Biol , 13, 3706-3713.
38. Rodriguez-Viciana, P , Warne, P. H , Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D. and Downward, J. (1994) Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature, 370, 527-532.
39. Yao, R. and Cooper, G. M. (1995) Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science, 267, 2003-2006.
40. Bedi, A., Zehnbauer, B. A., Barber, J. P., Sharkis, S. J., Jones, R. I. (1994) Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood, 83, 2038-2046.
41. Varticovski, L., Harrison-Findik, D. Keeler, M. L and Susa, M. (1994) Role of PI 3-kinase in mitogenesis. Biochem. Biophys. Acta, 1226, 1-11.